Copyright Reports & Markets. All rights reserved.

Global Medical Inhaler Market Research Report 2021

Request for Sample of this report
Buy now

1 Medical Inhaler Market Overview

  • 1.1 Product Overview and Scope of Medical Inhaler
  • 1.2 Medical Inhaler Segment by Type
    • 1.2.1 Global Medical Inhaler Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Pressurised Metered Dose Inhaler (PMDI)
    • 1.2.3 Dry Powder Inhaler (DPI)
    • 1.2.4 Others
  • 1.3 Medical Inhaler Segment by Application
    • 1.3.1 Medical Inhaler Sales Comparison by Application: (2021-2027)
    • 1.3.2 Asthma
    • 1.3.3 Chronic Obstructive Pulmonary Disease (COPD)
    • 1.3.4 Allergic Rhinitis
  • 1.4 Global Medical Inhaler Market Size Estimates and Forecasts
    • 1.4.1 Global Medical Inhaler Revenue 2016-2027
    • 1.4.2 Global Medical Inhaler Sales 2016-2027
    • 1.4.3 Medical Inhaler Market Size by Region: 2016 Versus 2021 Versus 2027

2 Medical Inhaler Market Competition by Manufacturers

  • 2.1 Global Medical Inhaler Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Medical Inhaler Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Medical Inhaler Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Medical Inhaler Manufacturing Sites, Area Served, Product Type
  • 2.5 Medical Inhaler Market Competitive Situation and Trends
    • 2.5.1 Medical Inhaler Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Medical Inhaler Players Market Share by Revenue
    • 2.5.3 Global Medical Inhaler Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Medical Inhaler Retrospective Market Scenario by Region

  • 3.1 Global Medical Inhaler Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Medical Inhaler Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Medical Inhaler Market Facts & Figures by Country
    • 3.3.1 North America Medical Inhaler Sales by Country
    • 3.3.2 North America Medical Inhaler Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Medical Inhaler Market Facts & Figures by Country
    • 3.4.1 Europe Medical Inhaler Sales by Country
    • 3.4.2 Europe Medical Inhaler Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Medical Inhaler Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Medical Inhaler Sales by Region
    • 3.5.2 Asia Pacific Medical Inhaler Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Medical Inhaler Market Facts & Figures by Country
    • 3.6.1 Latin America Medical Inhaler Sales by Country
    • 3.6.2 Latin America Medical Inhaler Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Medical Inhaler Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Medical Inhaler Sales by Country
    • 3.7.2 Middle East and Africa Medical Inhaler Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Medical Inhaler Historic Market Analysis by Type

  • 4.1 Global Medical Inhaler Sales Market Share by Type (2016-2021)
  • 4.2 Global Medical Inhaler Revenue Market Share by Type (2016-2021)
  • 4.3 Global Medical Inhaler Price by Type (2016-2021)

5 Global Medical Inhaler Historic Market Analysis by Application

  • 5.1 Global Medical Inhaler Sales Market Share by Application (2016-2021)
  • 5.2 Global Medical Inhaler Revenue Market Share by Application (2016-2021)
  • 5.3 Global Medical Inhaler Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 GSK
    • 6.1.1 GSK Corporation Information
    • 6.1.2 GSK Description and Business Overview
    • 6.1.3 GSK Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 GSK Product Portfolio
    • 6.1.5 GSK Recent Developments/Updates
  • 6.2 AstraZeneca
    • 6.2.1 AstraZeneca Corporation Information
    • 6.2.2 AstraZeneca Description and Business Overview
    • 6.2.3 AstraZeneca Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 AstraZeneca Product Portfolio
    • 6.2.5 AstraZeneca Recent Developments/Updates
  • 6.3 Boehringer Ingelheim
    • 6.3.1 Boehringer Ingelheim Corporation Information
    • 6.3.2 Boehringer Ingelheim Description and Business Overview
    • 6.3.3 Boehringer Ingelheim Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Boehringer Ingelheim Product Portfolio
    • 6.3.5 Boehringer Ingelheim Recent Developments/Updates
  • 6.4 Chiesi
    • 6.4.1 Chiesi Corporation Information
    • 6.4.2 Chiesi Description and Business Overview
    • 6.4.3 Chiesi Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Chiesi Product Portfolio
    • 6.4.5 Chiesi Recent Developments/Updates
  • 6.5 Cipla
    • 6.5.1 Cipla Corporation Information
    • 6.5.2 Cipla Description and Business Overview
    • 6.5.3 Cipla Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Cipla Product Portfolio
    • 6.5.5 Cipla Recent Developments/Updates
  • 6.6 3M
    • 6.6.1 3M Corporation Information
    • 6.6.2 3M Description and Business Overview
    • 6.6.3 3M Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 3M Product Portfolio
    • 6.6.5 3M Recent Developments/Updates
  • 6.7 Hovione
    • 6.6.1 Hovione Corporation Information
    • 6.6.2 Hovione Description and Business Overview
    • 6.6.3 Hovione Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Hovione Product Portfolio
    • 6.7.5 Hovione Recent Developments/Updates
  • 6.8 Mannkind
    • 6.8.1 Mannkind Corporation Information
    • 6.8.2 Mannkind Description and Business Overview
    • 6.8.3 Mannkind Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Mannkind Product Portfolio
    • 6.8.5 Mannkind Recent Developments/Updates
  • 6.9 Mylan
    • 6.9.1 Mylan Corporation Information
    • 6.9.2 Mylan Description and Business Overview
    • 6.9.3 Mylan Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Mylan Product Portfolio
    • 6.9.5 Mylan Recent Developments/Updates
  • 6.10 Novartis
    • 6.10.1 Novartis Corporation Information
    • 6.10.2 Novartis Description and Business Overview
    • 6.10.3 Novartis Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Novartis Product Portfolio
    • 6.10.5 Novartis Recent Developments/Updates
  • 6.11 Teva
    • 6.11.1 Teva Corporation Information
    • 6.11.2 Teva Medical Inhaler Description and Business Overview
    • 6.11.3 Teva Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Teva Product Portfolio
    • 6.11.5 Teva Recent Developments/Updates
  • 6.12 Vectura
    • 6.12.1 Vectura Corporation Information
    • 6.12.2 Vectura Medical Inhaler Description and Business Overview
    • 6.12.3 Vectura Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Vectura Product Portfolio
    • 6.12.5 Vectura Recent Developments/Updates
  • 6.13 Adherium
    • 6.13.1 Adherium Corporation Information
    • 6.13.2 Adherium Medical Inhaler Description and Business Overview
    • 6.13.3 Adherium Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Adherium Product Portfolio
    • 6.13.5 Adherium Recent Developments/Updates
  • 6.14 Cohero Health
    • 6.14.1 Cohero Health Corporation Information
    • 6.14.2 Cohero Health Medical Inhaler Description and Business Overview
    • 6.14.3 Cohero Health Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Cohero Health Product Portfolio
    • 6.14.5 Cohero Health Recent Developments/Updates
  • 6.15 Opko
    • 6.15.1 Opko Corporation Information
    • 6.15.2 Opko Medical Inhaler Description and Business Overview
    • 6.15.3 Opko Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Opko Product Portfolio
    • 6.15.5 Opko Recent Developments/Updates
  • 6.16 ResMed
    • 6.16.1 ResMed Corporation Information
    • 6.16.2 ResMed Medical Inhaler Description and Business Overview
    • 6.16.3 ResMed Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 ResMed Product Portfolio
    • 6.16.5 ResMed Recent Developments/Updates
  • 6.17 Beximco Pharma
    • 6.17.1 Beximco Pharma Corporation Information
    • 6.17.2 Beximco Pharma Medical Inhaler Description and Business Overview
    • 6.17.3 Beximco Pharma Medical Inhaler Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Beximco Pharma Product Portfolio
    • 6.17.5 Beximco Pharma Recent Developments/Updates

7 Medical Inhaler Manufacturing Cost Analysis

  • 7.1 Medical Inhaler Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Medical Inhaler
  • 7.4 Medical Inhaler Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Medical Inhaler Distributors List
  • 8.3 Medical Inhaler Customers

9 Medical Inhaler Market Dynamics

  • 9.1 Medical Inhaler Industry Trends
  • 9.2 Medical Inhaler Growth Drivers
  • 9.3 Medical Inhaler Market Challenges
  • 9.4 Medical Inhaler Market Restraints

10 Global Market Forecast

  • 10.1 Medical Inhaler Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Medical Inhaler by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Medical Inhaler by Type (2022-2027)
  • 10.2 Medical Inhaler Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Medical Inhaler by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Medical Inhaler by Application (2022-2027)
  • 10.3 Medical Inhaler Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Medical Inhaler by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Medical Inhaler by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Pressurised Metered Dose Inhaler (PMDI)
    Dry Powder Inhaler (DPI)
    Others

    Segment by Application
    Asthma
    Chronic Obstructive Pulmonary Disease (COPD)
    Allergic Rhinitis

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    GSK
    AstraZeneca
    Boehringer Ingelheim
    Chiesi
    Cipla
    3M
    Hovione
    Mannkind
    Mylan
    Novartis
    Teva
    Vectura
    Adherium
    Cohero Health
    Opko
    ResMed
    Beximco Pharma

    Buy now